Summary of Significant Accounting Policies (Details - Antidilutive information) - shares	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
AntiDilutive Shares	472,660,142	472,660,142
Series A Preferred Stock [Member]
AntiDilutive Shares	1,376	1,376
Series B Preferred Stock [Member]
AntiDilutive Shares	19,876	19,876
Series C Preferred Stock [Member]
AntiDilutive Shares	68,388,890	68,388,890
Series D Preferred Stock [Member]
AntiDilutive Shares	4,250,000	4,250,000
Series E Preferred Stock [Member]
AntiDilutive Shares	400,000,000	400,000,000
Series A Convertible Stock [Member]
Basis of conversion	688 shares outstanding
Dilution	1 share A: 2 shares
Series B Convertible Stock [Member]
Basis of conversion	9,938 shares outstanding
Dilution	1 share B: 2 shares
Series C Convertible Stock [Member]
Basis of conversion	6,838,889 shares outstanding
Dilution	1 share C: 10 shares
Series D Convertible Stock [Member]
Basis of conversion	425,000 shares outstanding
Dilution	1 share D: 10 shares
Series E Convertible Stock [Member]
Basis of conversion	4,000,000 shares outstanding
Dilution	1 share E: 100 shares